Solara Active Pharma Sciences Shows Mildly Bullish Trend Amid Mixed Financial Indicators
Solara Active Pharma Sciences has experienced a change in its technical outlook, moving towards a mildly bullish trend. The company reported a profit after tax of Rs 5.99 crore and a ROCE of 6.10%. However, it faces challenges with declining operating profits and a high debt to EBITDA ratio.
Solara Active Pharma Sciences has recently undergone an adjustment in its evaluation, reflecting a shift in its technical outlook. The stock's technical trend has transitioned from a sideways movement to a mildly bullish stance, indicating a change in market sentiment. In terms of key financial metrics, Solara Active has reported a positive performance in its latest quarterly results, with a profit after tax of Rs 5.99 crore and a return on capital employed (ROCE) reaching 6.10%. The company's debtors turnover ratio stands at 3.93 times, showcasing effective management of receivables. Over the past year, the stock has generated a return of 15.06%, significantly outperforming the BSE500 index in various time frames, including the last three years.
Despite these positive indicators, the company faces challenges with a -8.32% compound annual growth rate in operating profits over the last five years and a high debt to EBITDA ratio of 6.20 times, which raises concerns about its ability to service debt. Additionally, 34.64% of promoter shares are pledged, which could exert downward pressure on stock prices in adverse market conditions.
For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
